#Stents are the type of small expandable tubes | Explore Tumblr Posts and Blogs

healthcaretechnologynews · 1 year

Text

Exploring Cardiovascular Stents: Global Innovations in Cardiac Care

Introduction

Cardiovascular diseases remain a leading cause of mortality worldwide. The health of our hearts is crucial because it can prevent heart attacks and blocked arteries. Fortunately, cardiac treatment has advanced significantly in modern medicine. One such development that has completely changed the industry is the cardiovascular stent. We will delve into the realm of cardiovascular stents in this blog, discussing their importance in improving cardiac health as well as the various varieties and advantages they provide.

Read Full Blog Here: https://www.grgonline.com/post/enhancing-cardiac-health-exploring-the-world-of-cardiovascular-stents

Understanding Cardiovascular Stents

Cardiovascular stents are small, mesh-like devices designed to support and keep the arteries open. They play a pivotal role in the treatment of coronary artery disease (CAD), a condition where the arteries supplying blood to the heart become narrowed or blocked due to the buildup of fatty deposits known as plaque. When these arteries are blocked, it can lead to chest pain (angina) or even a heart attack.

The Stent Procedure

The stent placement procedure, known as percutaneous coronary intervention (PCI) or angioplasty, is minimally invasive and typically performed in a catheterization lab. Here's how it works:

Insertion of Catheter: A thin, flexible tube (catheter) is inserted into a blood vessel, often in the groin or wrist, and guided through the arteries to the site of the blockage.

Balloon Inflation: A deflated balloon attached to the catheter is inflated at the blockage site. This compresses the plaque and widens the artery, restoring blood flow.

Stent Placement: The stent, which is mounted on a balloon, is then positioned at the narrowed area. When the balloon is inflated, the stent expands, locking into place and keeping the artery open.

Balloon Removal: The balloon is deflated and removed, leaving the stent in place.

Types of Cardiovascular Stents

There are two primary types of cardiovascular stents:

Drug-Eluting Stents (DES): These stents are coated with medications that are slowly released into the artery over time. These drugs help prevent the artery from re-narrowing (restenosis) by inhibiting cell growth. DES are often preferred for complex lesions.

Bare-Metal Stents (BMS): These stents are uncoated and are typically used in simpler blockages. While they are effective at holding the artery open, they may have a slightly higher risk of restenosis compared to DES.

Advancements in Cardiovascular Stents

Reduced Risk of Thrombosis: Advanced stent designs and coatings have significantly reduced the risk of stent thrombosis, a potentially life-threatening complication.

Enhanced Biocompatibility: The development of stents that mimic the body's natural response to injury has improved biocompatibility, reducing the likelihood of adverse reactions.

Enhanced Drug Delivery: Drug-eluting stents have seen significant advancements, with improved drug formulations and coatings that optimize therapeutic outcomes and reduce complications.

In conclusion, cardiovascular stents have come a long way, and their continued evolution is a testament to the commitment of medical researchers and engineers to enhance heart health. As we move forward, these innovations hold the promise of further improving the lives of individuals battling cardiovascular disease, ensuring that more hearts keep beating strong.

Visit our website now: https://www.grgonline.com/

#heart health #stents #Stent Technology #Heart Health Tech #vascularhealth #Stent Research

0 notes

manglamplusmedicityhospital · 2 years

Text

Angioplasty and Stent Placement

Coronary angioplasty is a procedure which used to open up the clogged and blocked heart arteries. Angioplasty uses a tiny balloon catheter that is inserted in a blocked blood vessel to help widen it and enhance the blood flow to heart. It is often done with the placement of a small wire mesh tube called a stent. The stent helps prop the artery open, reducing the risk of narrowing again. Most stents are coated with medication to help keep the artery open. Angioplasty can remove the signs and symptoms of blocked arteries, such as chest pain and shortness of breath. Angioplasty is often used during a heart attack to quickly open a blocked artery and reduce the amount of damage to the heart.

Why to perform it?

Angioplasty is used to treat the build-up of fatty plaques in the heart's blood vessels. This build up is a type of heart disease known as atherosclerosis. Depending on the extent of your heart disease and your overall health condition, heart specialist doctor in Jaipur will whether angioplasty should be done or not.

Preparation required

Before a scheduled angioplasty, a heart specialist will review your medical history and perform a physical examination. You might need to have some tests, including a chest X-ray, electrocardiogram and blood tests, before the procedure. The doctor will perform an imaging test called a coronary angiogram to see if the arteries to your heart are blocked and if they can be treated with angioplasty.

If the heart specialist doctor in Jaipur finds a blockage during your coronary angiogram, he might decide to perform angioplasty and stenting immediately after the angiogram while your heart is still catheterized.

You might feel pressure in the area where the catheter is inserted. You might also feel a mild discomfort when the balloon is inflated and your artery is stretched, but one shouldn't feel any sharp pain during the procedure.

Stent placement

Most individuals who have angioplasty also have a stent placed in their blocked artery during the same procedure. A stent, which looks like a tiny coil of wire mesh, supports the walls of your artery and helps prevent it from re-narrowing after angioplasty.

Procedure of Stent Placement:

The stent, which is collapsed around a balloon at the tip of the catheter, is guided through the artery to the blockage.

At the blockage, the balloon is inflated and the spring-like stent expands and locks into place inside the artery.

The stent stays in the artery permanently to hold it open and improve blood flow to your heart. In some cases, more than one stent may be needed to open a blockage.

X-ray images (angiograms) are taken to see how well blood flows through your newly widened artery.

Most stents implanted during an angioplasty are drug coated. The medication in the stent is slowly released to help prevent future plaque build-up and the re-narrowing of the blood vessel.

Outcome:

Coronary angioplasty performed by the heart specialist doctor in Jaipur greatly enhances blood flow through the previously narrowed or blocked coronary artery. Chest pain generally decreases. One may be better able to exercise.

#heart #specialist #doctor #hospital #medicity

0 notes

fmihealthcare-blog · 6 years

Text

Endovascular Therapy Devices Market is expected to register a healthy CAGR during the forecast period.

Endovascular therapy Devices: Market Insights

A procedure involving endovascular therapy devices are used to insert a flexible, sterile plastic tube, stents or a catheter into a blood vessel to allow blood to be withdrawn from or medication to be delivered to a patient’s bloodstream over a period of time. These endovascular therapy devices can be used either for intravenous antibiotic treatment, chemotherapy, long-term intravenous feeding and blood transfusions. The market is challenged by many medical complexities requiring cardiovascular disease treatment from inside the blood vessel, strokes and other cardiovascular conditions. The market of endovascular therapy devices contains products which are less invasive, requiring patients to spend less time in the hospital, less recovery time and devices which cause less pain. The endovascular therapy devices market is dominated by minimally invasive, catheter-based procedure. These procedures are often performed in a cardiac catheterization labs present in hospitals.

Endovascular therapy Devices: Market Dynamics

The global endovascular therapy devices market will increase in forecast period 2018-28. Endovascular therapy devices market will be driven primarily by the rise in incidence of cardiovascular patients, economic power in some regions leading to lifestyle change, growing disposable income and, increasing expenditure. In addition, recent developments in stent technology and increased experience of interventionists will propel the growth of the global endovascular therapy devices market in the future. However, high cost involved in usage of new endovascular therapy devices, less awareness in economically poor nations, and US’s stringent tax regulation rules on medical devices are expected to be some of the major restraints in global market for endovascular therapy devices market.

Request Sample Report @https://www.futuremarketinsights.com/reports/sample/rep-gb-7693

Endovascular therapy Devices Market: Segmentation

Segmentation by Product Type:

Percutaneous endovascular aneurysm repair (EVAR)

Fenestrated EVAR

Aortic stents

Biodegradable Stents

Self-expanding Nitinol Stents

Thoracic aortic aneurysms grafts

Other Devices

Segmentation by Procedures:

Balloon Angioplasty

Angioplasty with Stent Placement

Drug-Eluting Stents (DES)

Renal Artery Angioplasty and Stenting

Carotid Artery Stenting

Transfemoral Carotid Artery Stenting

Transcarotid Artery Revascularization

Intravascular Brachytherapy

Atherectomy

Thrombolysis

Segmentation by Application

Pulmonary

Vascular

Cardiology

Surgery

Neurology

Radiology

Segmentation by End User Type:

Hospitals

Clinics

Research Institutes

Endovascular therapy Devices Market: Overview

The endovascular therapy devices market has grown exponentially since its inception in the early 1990s. Global estimates for the market reflects several factors. The use of manual compression has significantly lowered down in obese patients or patients on anticoagulation. However, complex procedures performed with a percutaneous endovascular therapy devices have taken strides as they offer bigger sheath sizes. As the economic landscape of health care becomes more competitive, endovascular therapy devices are becoming increasingly valuable because it frees up time for other work. Current market trends are focused on developing endovascular therapy devices that can be safe and efficient enough to close large-caliber femoral arteriotomies. As transcatheter aortic valve repair and percutaneous endovascular aneurysm repair are increasing in popularity, there will be tremendous opportunity for the manufacturers in the market to develop and manufacture simple but effective endovascular therapy devices in future..

Endovascular therapy Devices Market: Region-wise Outlook

Globally, global Endovascular therapy Devices market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East. North America will account for the largest share in global Endovascular therapy Devices market. Besides the region’s Endovascular therapy Devices market growth will also increase due to obesity and diet, and new products lunch due to presence of leading manufacturers in the region. Europe with robust healthcare infrastructure, will drive the endovascular therapy devices market in this region. Technological advances in the region in the past decade have shifted revascularization strategies from traditional open surgical approaches. Focus has shifted towards lower-morbidity percutaneous endovascular treatments for patients with peripheral arterial disease. Asia Pacific mainly including India, China, AUS&NZ and Latin American countries are expected to be a significant market contributors in the rising Endovascular therapy Devices market. Advancements in stent designs by leading and local manufacturers in the region have fueled the growth of endovascular therapy devices in the region due liberalization of healthcare polices and trade related implications.

Request to View TOC @ https://www.futuremarketinsights.com/toc/rep-gb-7693

Endovascular therapy Devices Market: Key Players

Some of the key players present in global Endovascular therapy Devices market include Cardinal Health, Altura Medical, Lifetech Scientific BiFlow Medical, Boston Scientific, Endospan, Getinge, InspireMD, Japan Lifeline, Lombard Medical Technologies, Endologix, Medtronic, Nellix, Penumbra and Terumo. In addition presence of small and local manufacturers across the countries will account for competiveness in Endovascular therapy Devices market.

1 note · View note

vicky8588 · 3 years

Text

Coronary Stents Market, Size, Share, Outlook and Growth Opportunities 2021-2028

Market Overview

·Global Coronary Stents Market is expected to grow at a CAGR of 7.90% during the forecast period 2021-2028.

· Stents are small expandable mesh tubes that are inserted to keep clogged arteries open after a balloon angioplasty procedure.

· This is a minimally invasive procedure to restore proper blood flow through the heart. The stent is inserted during, or immediately, after balloon angioplasty, which prevents the artery from closing up again. Coronary artery stents, typically a metal framework, can be placed inside the artery.

· Coronary stents are used in a procedure called percutaneous coronary intervention (PCI). Coronary stents are now used in more than 90% of PCI procedures. Stents reduce angina (chest pain) and improve survivability and decrease adverse events in acute myocardial infarction.

Download free sample: https://www.datamintelligence.com/download-sample/coronary-stents-market

Market Dynamics

· Rising incidences of heart diseases are one of the major factor driving the growth of global coronary stents market.

· According to the National Center for Chronic Disease, around 610,000 people die of heart disease in the United States every year.

· According to the World Health Organization (WHO), Cardiovascular Disease causes an estimated 17 million deaths each year worldwide, accounting for one-third of all deaths worldwide.

· According to WHO, coronary heart disease is now the leading cause of death worldwide. An estimated 3.8 million men and 3.4 million women die each year from coronary heart disease.

· In Europe coronary heart disease accounts for an estimated 1.95 million deaths each year. In the United Kingdom, 1.3 million people have angina, and an estimated 330 000 people have a heart attack each year.

Segmentation Analysis

· The global coronary stents are segmented on product type, which includes bare-metal stents, drug-eluting stents, bioabsorbable stents. Drug-eluting are tents holds the dominant market share in 2018, and it is expected to remain dominant over the forecast period, due to the increasing launches and approval of drug-eluting stents by the regulatory bodies.

· For instance, in March 2017, Medtronic plc has received U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Resolute Onyx Drug-Eluting Stent (DES). The Resolute Onyx DES is the first and only DES to feature Core Wire Technology.

· In May 2018, Abbott Laboratory has received U.S. Food and Drug Administration (FDA) approval for XIENCE Sierra. XIENCE stents are among the world’s most-used and studied stents and have an exceptional safety record with low rates of complications. Design and technology advances in this generation of XIENCE include features specifically designed for the treatment of complex blockages that now account for up to 70% of cases.

· In January 2018, BIOTRONIK received approval for its Orsiro1 coronary drug-eluting stent (Orsiro DES) from the Japanese Ministry of Health.

· In September 2018, Terumo Corporation introduced its Ultimaster Tensei drug-eluting stent (DES) in Japan market. Ultimaster Tensei DES allows physicians to reach and treat complex anatomies both with radial and femoral access with confidence based on the results of a comprehensive clinical program of Ultimaster DES.

Geographical Share

· North America was dominating the coronary stents market in 2018, and it is expected to remain dominant over the forecast period, due to rising incidences of heart diseases in this region.

· According to the National Center for Chronic Disease, around 610,000 people die of heart disease in the United States every year.

· Moreover, the increasing launches and approval of coronary stents by the regulatory bodies is the key factor driving the North America coronary stents market.

· For instance, in September 2018, Boston Scientific has received U.S. Food and Drug Administration (FDA) premarket approval for its Eluvia Drug-Eluting Vascular Stent System, specially developed for the treatment of peripheral artery disease (PAD).

· In September 2018, Cook Medical introduced its new 5 mm diameter version of Zilver PTX was approved by the FDA.

· It is the first 5 mm drug-eluting stent in the U.S. with lengths available up to 140 mm that is indicated to treat vessels as small as 4mm in diameter, to treat patients with lesions in their superficial femoral arteries (SFA).

· In November 2017, Cordis, a Cardinal Health company, and Medinol received U.S Food and Drug Administration (FDA) approval for EluNIR drug-eluting stent (DES) for the treatment of patients with narrowing or blockages to their coronary arteries.

Competitive Trends

· The new product launch and approval of coronary stents by the regulatory bodies is one of the critical factor driving the global coronary stents market.

· For instance, in February 2017, Cook has extended its Zilver PTX product portfolio with a 140mm drug-eluting stent. Physicians will now be able to treat longer lesions with just one stent, which is deployed via a thumbwheel delivery system.

· In May 2018, B. Braun Interventional Systems Inc. (BIS) in collaboration with NuMED Inc., has announced the U.S. Food and Drug Administration pre-market approval and U.S. commercial launch of an expanded size offering and a new indication for the Cheatham-Platinum (CP) Stent portfolio.

· Moreover, the increasing competitive strategies between companies for increasing their market share for coronary stents is one of the critical factor driving the global coronary stents market.

· For instance, in May 2016, Cordis, Cardinal Health entered into a distribution agreement with Biosensors that enables Cordis, Cardinal Health’s interventional vascular business, to sell the coronary stent portfolio of Singapore-based Biosensors International Group, Ltd. to the selected countries in Europe, the Middle East, Africa, Australia, and New Zealand.

· In June 2018, Cook Medical partnered with Taewoong Medical to distribute a selection of stents into the U.S. The new partnership includes the Niti-S Self-Expandable line of metal GI stents. Cook Medical has begun the distribution of Taewoong portfolio on November 1, 2018.

View full report: https://www.datamintelligence.com/research-report/coronary-stents-market

Enquiry before buying: https://www.datamintelligence.com/enquiry/coronary-stents-market

About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: [email protected]

Tel: +1 877 441 4866

Website: www.datamintelligence.com

#Bare-metal Stents Drug-Eluting Stents Bioabsorbable Stents) By Material (Metallic Polymeric Natural Biomaterial

0 notes

market-researchm · 3 years

Text

Coronary Stents Market: In-depth Study by Key Reasons, Product Segments and Application to 2024

The global Coronary Stent Market is predicted to reach USD 15.18 billion by 2024 owing to factors include technological advancements, rising load of CAD, growing number of PCI procedures (percutaneous coronary intervention), increasing geriatric population and increasing demand for user-friendly procedures. A coronary stent is a miniature tube that is used to open a narrowed artery during the PCI (percutaneous coronary intervention) procedure. This treatment comprises insertion of balloon-tipped tube in the artery which is transported to the blockage location. The stent enlarges and forms a platform after the balloon inflates. This helps the artery to open and stabilize the blood flow to the heart. The Coronary stents are used in the treatment of cardiac disorders like angina pain, myocardial infarction and coronary artery disease. The Coronary Stent Market is expected to grow significantly with CAGR of 6.2% in the forecast period.

The Coronary Stent prevents the heart attack that is caused by the narrowing of coronary arteries. The stent is made of cobalt alloy or stainless steel tube and is attached to small balloons that support to proper blood flow and take care of the vessel wall. The coronary heart disease treatments comprise balloon angioplasty, pharmaceuticals, stenting of coronary artery bypass grafting. Stenting is regarded efficient for the heart patients in comparison to the bypass heart surgery. It is free of any major operation since it can be performed with the support of local low sedation and anesthesia.

Get Free PDF Sample Copy of the Report (Including Full TOC, List of Tables & Figures) @ https://www.millioninsights.com/industry-reports/coronary-stent-market-size/request-sample

The main driver for the growth of coronary stent industry is the rising prevalence of heart diseases. Owing to the rising elderly population across globe, particularly in the developed economies, the market expects wide opportunities in the different parts of the world. Other factors that drive the market are the genetic diseases like obesity that is prevailing in all the age groups due to the changing unhealthy lifestyle and the technological advancements of bio-absorbable stents.

The main reason for maximum amount of deaths caused by the heart diseases across the globe is the CAD (Coronary artery disease). Nevertheless, the number of Coronary Artery Disease patients has decreased due to the increasing number of PCIs (percutaneous coronary interventions). This procedure makes use of wide range of coronary stents which again drives the industry growth. Besides, the expansion of BVS (bio resorb able vascular scaffold) and the emergence of the coronary stent market offer considerable growth opportunities. Moreover, the alternative treatment methodologies of CAD, numerous cases of product failure and strict regulations for product approval will restrict the market growth in the forthcoming years.

The coronary stent industry is categorized on the grounds of product type, delivery modes, material, end-user and geographic region. On the grounds of product type, the market is divided into drug-eluting stents, bare-metal stents and bio absorbable stents. In the forecast period, the drug-eluting stents section is predicted to capture maximum share of the market. This is because the drug-eluting stents possess more benefits than the bare-metal stents and bio absorbable stents. The benefits can be stated as reduced risk of restenosis and other major disorders. On the grounds of delivery modes, the coronary stent market is divided into self-expanding stents and balloon-expanding stents. The balloon expandable stents is predicted to capture larger market share due to the factors like increasing regulatory approvals for balloon-expandable stents, greater use of these stents and growing research activities to enhance technology.

Geographically, the Coronary Stents Market is divided into Europe, North America and Asia, and the rest of the world. North America is estimated to capture comparatively larger market share followed by Europe. Asia is projected to capture the coronary stents industry with a good pace in the coming years. Other factors for the growth of the market in Asia include growing population base, prevalence of heart disease, focus of major players, increasing adoption of modern technologies and lower manufacturing costs in the area.

The prominent and emerging market players of coronary stent market are Abbott Laboratories, Boston Scientific Corporation, Biosensors International Group, Ltd., B. Braun Melsungen AG, Terumo Corporation, Medtronic, plc, BIOTRONIK SE & Co. KG, STENTYS SA, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Translumina GmbH, and Vascular Concepts.

Access Full Research Report @ https://www.millioninsights.com/industry-reports/coronary-stent-market-size

#Coronary Stent Market #Coronary Stents Industry #Coronary Stent Market Growth #Coronary Stents Market Analysis #Coronary Stent Market Size #Coronary Stents Market Share #Coronary Stent Market Report #Coronary Stents Industry Trends #Coronary Stent Market Research

0 notes

apex970 · 3 years

Text

What is Heart Surgery?

Heart-related problems do not always require surgery. Sometimes they can be resolved through lifestyle changes, medications, or non-surgical procedures. For example, catheter ablation uses energy to create small scars in the heart tissue to prevent abnormal electrical signals from passing through your heart. Coronary angioplasty is a minimally invasive surgery in which a stent is inserted into a narrowed or blocked coronary artery to keep it open. However, surgery is often required to solve problems such as heart failure, plaque buildup that partially or completely blocks coronary blood flow, heart valve defects, dilated or diseased major blood vessels (such as the aorta), and abnormal heart rhythms. Apex Wellness Hospital is the best cardiac hospital in Nashik with a team of experienced cardiologists who diagnose the heart for treating heart-related diseases.

What types of heart surgery are there?

There are many types of heart surgery. The National Heart, Lung, and Blood Institute of the National Institutes of Health lists the following most common coronary surgery procedures:

Coronary artery bypass grafting (CABG) - In CABG, the most common type of cardiac surgery, the surgeon removes healthy arteries or veins from another part of the body and connects them to supply blood through blocked coronary arteries. The transplanted artery or vein bypasses the blocked part of the coronary artery and creates a new path for blood to flow to the heart muscle. This is usually done on more than one coronary artery in the same operation.

Repair or replacement of heart valves - Surgeons either repair the valve or replace it with an artificial valve or a biological valve made from pig, bovine, or human heart tissue. One repair option is to insert a catheter into a large blood vessel, guide it into the heart, and then inflate and deflate a small balloon at the tip of the catheter to expand the narrowed valve.

ICD - Drugs are usually the first choice for treatment of arrhythmia, which is a condition in which the heart beats too fast, too slow, or the rhythm is irregular. If the medication does not work, the surgeon can implant a pacemaker under the skin on the chest or abdomen and connect it to the ventricle with wires. When the sensor detects an abnormality, the device uses electrical pulses to control the heart rate. ICD works in a similar way, but it sends out electric shocks to restore normal heart rhythm when a dangerous arrhythmia is detected.

Labyrinth surgery - The surgeon forms a pattern of scar tissue in the upper chamber of the heart to redirect electrical signals along a controlled path to the lower chamber of the heart. Surgery blocked the parasitic electrical signals that cause atrial fibrillation, which is the most common type of severe arrhythmia.

Repair aneurysms - The weak part of the artery or heart wall is replaced with a patch or graft to repair the balloon-like bulge in the artery or myocardial wall.

Heart transplant - The diseased heart is removed and replaced with a healthy heart from the deceased donor.

Insert a ventricular assist device (VAD) or a total artificial heart (TAH) - VAD is a mechanical pump that supports heart function and blood flow. Two lower chambers are replaced by TAH.

In addition to these procedures, an increasingly common alternative to minimally invasive open-heart surgery is transcatheter structural heart surgery. This involves guiding an elongated flexible tube called a catheter to the heart through a blood vessel that can enter from the groin, thigh, abdomen, chest, neck, or collarbone. A small incision is necessary. This type of surgery includes the implantation of a transcatheter aortic valve, the replacement of a defective aortic valve with a valve made of animal tissue, the placement of MitraClip® to treat mitral valve abnormalities, and the placement of WATCHMAN® to treat patients with non-valvular atrial fibrillation.

What is the recovery time?

Recovery time depends on the type of heart surgery you had. Surgeons will ask you to spend a day or more in the hospital. You will then be transferred to another part of the hospital for a few days until you go home.

The National Heart, Lung, and Blood Institute points out that the length of time you recover at home depends on the type of surgery you performed, your health before the surgery, and whether you experienced surgical complications. For example, a full recovery from traditional coronary artery bypass surgery may take 6 to 12 weeks or more.

Medical anesthesiologists are the most skilled medical experts in the fields of anesthesia care, pain management, and intensive care medicine. The education and training they receive can in some cases mean the difference between life and death.

#cardiology #cardiologists #heartsurgery #hearttreatment

0 notes

marketresearchhealthcarefuture · 3 years

Text

Coronary Stent Market Size Report Analysis, Trends, Size, Competitive Landscape 2027

Synopsis of the Global Coronary Stent Market

Coronary stents are small stretchy tube-like devices used to expand the arteries of the patient in order to prevent blockage. A coronary stent is inserted into the artery of a patient suffering from a coronary disease due to the build-up of plaque. It is used for widening the narrowed arteries, and it helps in reducing chest pain and the chance of heart attack

The global coronary stent market is mainly driven by the high prevalence of heart-related diseases and huge demand for diagnosis and treatment methods. Additionally, the increasing availability of diagnostic services for coronary heart diseases also fuels the growth of the market. Moreover, favorable reimbursement policies are likely to boost the market growth.

also read @ https://www.marketwatch.com/press-release/coronary-stent-global-market-industry-analysis-growth-trends-opportunity-and-forecast-2018-to-2023-2021-01-17

Coronary Stent Market Overview

Coronary stents are a small tube-like device that is placed into the coronary arteries of a patient in order to keep the arteries open in the coronary heart disease treatment and prevent the same from any kind of blockage. It is used for broadening the narrowed arteries and helps curb-down chest pain and the chances of heart attack. According to the recently published report by the team of Market Research Future (MRFR), the global coronary stent market is projected to grow at a rate of 7.8% during the review period.

The market is identified to be driven by a number of factors, including the wide-spread prevalence of heart-related diseases and a proliferating demand for diagnosis and treatment methods. Additionally, the growing availability of diagnostic services for coronary heart diseases is also pushing the growth of the market. A growing percentage of positive outcomes with stenting and the emergence of a number of advancing technologies in the coronary artery field is adding to the market growth of the device. It is also worth noting that alternative treatment methods for curing coronary artery diseases and a number of product recall cases are likely to hinder the market growth of coronary stents.

Coronary Stent Market Segmentation

Global coronary stent market segmentation is classified on the basis of mode of delivery, type, material, and end-user.

By type, the market segments into drug-eluting stents, bioabsorbable stents, and bare-metal stents.

By material, the market comprises cobalt chromium, metallic stents, stainless steels, platinum chromium, nickel titanium, and others.

By end-user, the market includes hospitals and clinics, ambulatory surgical centers, cardiac centers, and others.

By mode of delivery, the market divides into self-expanding and balloon-expandable stents.

Coronary Stent Market Regional Analysis

segments into North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa.

North America is the dominant region of the lot and is primarily driven by the surging patient population suffering from coronary heart diseases, an increasing pool of geriatric population, and growing investments in the healthcare sector. Latin America, on the other hand, is slated to be one of the fastest growing regional market owing to the rising demand for coronary heart disease treatment options and the availability of technologically advanced devices for diagnosis purposes.

With Germany and the UK being the major contributors, the European coronary stent market is expected to flourish in the forthcoming years. An increasing emphasis on the diagnosis and treatment of heart and other related diseases has majorly driven the market in this region. The increasing healthcare expenditure is another key contributor to the market’s growth.

Asia-Pacific stands out as the fastest growing market amongst all the mentioned regions. This projection can be primarily attributed to the increasing prevalence of cardiovascular diseases and a rising focus on performing early diagnosis and treatment of heart diseases. The Middle East & African region is forecasted to exhibit a slow and steady rise in the growth ladder. The regional market is starting to show positive signs with an increasing number of healthcare facilities offering treatments for chronic diseases and an increasing growth of the medical device sector, especially for diagnostic devices. In Africa, increasing awareness concerning coronary heart diseases is pushing the market growth herein.

Coronary Stent Market Competitive Landscape

Coronary Stent Market Sizeincludes some highly noteworthy players including B. Braun Melsungen AG (Germany), MicroPort Scientific Corporation (China), Vascular Concepts (India), Terumo Corporation (Japan), BIOTRONIK SE & Co. KG (Germany), Translumina GmbH (Germany), Biosensors International Group, Ltd. (Singapore), Meril Life Sciences Pvt. Ltd. (India), Elixir Medical Corporation (U.S.), Boston Scientific Corporation (U.S.), STENTYS SA (France), Medtronic plc (Ireland), Abbott Laboratories (U.S.), Reva Medical Inc. (U.S.), and others.

Coronary Stent Industry Overview

Feb 8th, 2019, CeloNova BioSciences, Inc. (CeloNova), an innovative global medical device leader, announced the signing of a three-year group purchasing agreement with HealthTrust for their new game-changing Coronary Stent named COBRA PzF(TM) NanoCoated Coronary Stent (NCS) System.

Feb 22nd, 2019, Biotronic announced the approval of Osiro, an ultrathin-strut coronary stent, from the US Food and Drug Administration for the treatment of coronary artery disease. It was approved in Europe eight years back and has been implanted upon millions of patients globally.

Get More Information on Coronary Stent Market Research Report – Forecast to 2023 @

https://www.marketresearchfuture.com/reports/coronary-stent-market-5915

RELATED REPORTS

Global Invisible Orthodontics Market Research Report—Forecast till 2025

Global Pain Patch Market Research Report—Forecast till 2025

Body Composition Analyzers Market Research Report - Global Forecast till 2025

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services

0 notes

marketanalysisdata · 3 years

Text

Coronary Stent Market Share and Growth Information Analysis Report by 2024

19th April 2021 – The Global Coronary Stent Market is predicted to reach USD 15.18 billion by 2024 owing to factors include technological advancements, rising load of CAD, growing number of PCI procedures (percutaneous coronary intervention), increasing geriatric population and increasing demand for user-friendly procedures. A coronary stent is a miniature tube that is used to open a narrowed artery during the PCI (percutaneous coronary intervention) procedure. This treatment comprises insertion of balloon-tipped tube in the artery which is transported to the blockage location. The stent enlarges and forms a platform after the balloon inflates. This helps the artery to open and stabilize the blood flow to the heart. The Coronary stents are used in the treatment of cardiac disorders like angina pain, myocardial infarction and coronary artery disease. The Coronary Stent Market is expected to grow significantly with CAGR of 6.2% in the forecast period.

The Coronary Stent prevents the heart attack that is caused by the narrowing of coronary arteries. The stent is made of cobalt alloy or stainless steel tube and is attached to small balloons that support to proper blood flow and take care of the vessel wall. The coronary heart disease treatments comprise balloon angioplasty, pharmaceuticals, stenting of coronary artery bypass grafting. Stenting is regarded efficient for the heart patients in comparison to the bypass heart surgery. It is free of any major operation since it can be performed with the support of local low sedation and anesthesia.

Access Coronary Stent Market Report with TOC @ https://www.millioninsights.com/industry-reports/coronary-stent-market-size

The main driver for the growth of coronary stent industry is the rising prevalence of heart diseases. Owing to the rising elderly population across globe, particularly in the developed economies, the market expects wide opportunities in the different parts of the world. Other factors that drive the market are the genetic diseases like obesity that is prevailing in all the age groups due to the changing unhealthy lifestyle and the technological advancements of bio-absorbable stents. The main reason for maximum amount of deaths caused by the heart diseases across the globe is the CAD (Coronary artery disease). Nevertheless, the number of Coronary Artery Disease patients has decreased due to the increasing number of PCIs (percutaneous coronary interventions). This procedure makes use of wide range of coronary stents which again drives the industry growth. Besides, the expansion of BVS (bio resorb able vascular scaffold) and the emergence of the coronary stent market offer considerable growth opportunities. Moreover, the alternative treatment methodologies of CAD, numerous cases of product failure and strict regulations for product approval will restrict the market growth in the forthcoming years.

The coronary stent industry is categorized on the grounds of product type, delivery modes, material, end-user and geographic region. On the grounds of product type, the market is divided into drug-eluting stents, bare-metal stents and bio absorbable stents. In the forecast period, the drug-eluting stents section is predicted to capture maximum share of the market. This is because the drug-eluting stents possess more benefits than the bare-metal stents and bio absorbable stents. The benefits can be stated as reduced risk of restenosis and other major disorders. On the grounds of delivery modes, the coronary stent market is divided into self-expanding stents and balloon-expanding stents. The balloon expandable stents is predicted to capture larger market share due to the factors like increasing regulatory approvals for balloon-expandable stents, greater use of these stents and growing research activities to enhance technology.

Geographically, the Coronary Stents Market is divided into Europe, North America and Asia, and the rest of the world. North America is estimated to capture comparatively larger market share followed by Europe. Asia is projected to capture the coronary stents industry with a good pace in the coming years. Other factors for the growth of the market in Asia include growing population base, prevalence of heart disease, focus of major players, increasing adoption of modern technologies and lower manufacturing costs in the area.

The prominent and emerging market players of coronary stent market are Abbott Laboratories, Boston Scientific Corporation, Biosensors International Group, Ltd., B. Braun Melsungen AG, Terumo Corporation, Medtronic, plc, BIOTRONIK SE & Co. KG, STENTYS SA, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Translumina GmbH, and Vascular Concepts.

Request a Sample Copy of Coronary Stent Market Report @ https://www.millioninsights.com/industry-reports/coronary-stent-market-size/request-sample

0 notes

latestmarketresearchtrends-blog · 3 years

Text

Coronary Stent Market 2024 - Top Countries Data with Future Scope and Top Key Players Analysis